Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate for migraine prevention
2008-003736-38Phase 2Completed
- Sponsor
- BIAL
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine, migraine with aura and migraine without aura comparing Eslicarbazepine acetate with Placebo (2 arms). Primary endpoint: Absolute change from baseline in migraine attack frequency standardized to 4 weeks during the maintenance period. Started Dec 2008; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
migrainemigraine with auramigraine without aura
Beyond the preview
Go deeper on 2008-003736-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003736-38.